|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.21 INR | +19.99% |
|
+22.30% | +68.52% |
| Market Cap | 1.85TCr 19Cr 17Cr 16Cr 14Cr 27Cr 28Cr 185.84Cr 73Cr 925.83Cr 73Cr 72Cr 3.07TCr | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.85TCr 19Cr 17Cr 16Cr 14Cr 27Cr 28Cr 185.83Cr 73Cr 925.78Cr 73Cr 72Cr 3.07TCr | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
56.3% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +19.99% | ||
| 1 week | +22.30% | ||
| Current month | +21.42% | ||
| 1 month | +17.32% | ||
| 3 months | +67.13% | ||
| 6 months | +84.46% | ||
| Current year | +68.52% |
| 1 week | 54.96 |  | 69.21 |
| 1 month | 51.43 | | 69.21 |
| Current year | 33.44 | | 69.21 |
| 1 year | 33.44 | | 69.21 |
| 3 years | 31.31 | | 100.8 |
| 5 years | 23.65 | | 100.8 |
| 10 years | 7.21 | | 100.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 01/07/2026 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 01/02/1992 |
| Director of Finance/CFO | 59 | 03/04/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 01/02/1992 |
| Director/Board Member | 58 | 13/08/2019 | |
Savita
BRD | Director/Board Member | - | 22/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +19.99% | +22.30% | +19.82% | +127.66% | 33Cr | |
| -0.51% | -6.83% | +46.35% | +148.39% | 1LCr | |
| +0.20% | -4.14% | +52.35% | +49.40% | 61TCr | |
| -0.53% | -5.10% | +24.88% | +63.57% | 43TCr | |
| +0.48% | -0.67% | +39.13% | +34.00% | 35TCr | |
| +0.08% | -3.05% | +32.29% | +39.91% | 29TCr | |
| +2.09% | -8.91% | +5.73% | +7.71% | 24TCr | |
| +1.75% | -5.79% | -0.39% | -42.69% | 21TCr | |
| +2.94% | +3.66% | +31.37% | +69.06% | 20TCr | |
| +3.13% | +3.62% | +19.50% | +79.07% | 16TCr | |
| Average | +3.21% | -3.30% | +27.10% | +57.61% | 35.01TCr | |
| Weighted average by Cap. | +0.82% | -4.34% | +35.20% | +71.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.7TCr 18Cr 16Cr 14Cr 13Cr 25Cr 25Cr 170.77Cr 67Cr 850.75Cr 67Cr 66Cr 2.82TCr | 1.81TCr 19Cr 17Cr 15Cr 14Cr 27Cr 27Cr 181.77Cr 71Cr 905.58Cr 72Cr 70Cr 3TCr |
| Net income | 96Cr 1.01Cr 87.78L 81.84L 75.18L 1.42Cr 1.44Cr 9.65Cr 3.77Cr 48Cr 3.8Cr 3.71Cr 159.27Cr | 118.02Cr 1.24Cr 1.08Cr 1Cr 92.27L 1.75Cr 1.76Cr 12Cr 4.63Cr 59Cr 4.66Cr 4.56Cr 195.48Cr |
| Net Debt | 12Cr 12.67L 11L 10.26L 9L 17.82L 18.02L 1.21Cr 47.28L 6.03Cr 47.59L 46.54L 20Cr | -9L -9.76T -8.47T -7.9T -7.26T -13.72T -13.87T -93.12T -36.4T -5L -36.64T -35.83T -15.37L |
Employees
1,814
Sector
Pharmaceuticals
Calendar
12:15pm
Earnings release - Q1 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | ₹69.21 | +19.99% | 43,74,505 |
| 03/26/03 | ₹57.68 | +1.19% | 3,38,434 |
| 31/26/31 | ₹57.00 | +0.92% | 1,92,347 |
| 30/26/30 | ₹56.48 | -2.32% | 2,08,354 |
| 29/26/29 | ₹57.82 | +4.58% | 2,18,851 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
